GENEVA, Jan. 12 -- KYON BIOTECH AG (Hardturmstrasse 1038005 Zurich) filed a patent application (PCT/EP2025/068808) for "REPERFUSION INJURY OF THE LIVER AS A PROXY FOR CANCER TREATMENT" on Jul 02, 2025. With publication no. WO/2026/008686, the details related to the patent application was published on Jan 08, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TEPIC, Slobodan (c/o Kyon Biotech AGHardturmstrasse 1038005 Zurich)
Abstract: The present invention relates to a transient intentional ischemia of a part of the liver by occlusion of a selected hepatic vein, subsequently causing reperfusio...